Prognostic factors associated with mortality in acute exacerbations of idiopathic pulmonary fibrosis: A systematic review and meta-analysis

被引:0
|
作者
Pitre, Tyler [1 ]
Lupas, Daniel [2 ]
Ebeido, Ibrahim [3 ]
Colak, Alexander [4 ]
Modi, Mihir [2 ]
V. Kachkovski, George [3 ]
Montesi, Sydney B. [5 ]
Khor, Yet H. [6 ,7 ,8 ,9 ]
Kawano-Dourado, Leticia [10 ,11 ,12 ]
Jenkins, Gisli [13 ]
Fisher, Jolene H. [1 ]
Shapera, Shane [1 ]
Rochwerg, Bram [14 ,15 ]
Couban, Rachel [16 ]
Zeraatkar, Dena [14 ,16 ]
机构
[1] Univ Toronto, Dept Med, Div Respirol, Toronto, ON, Canada
[2] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[3] McMaster Univ, Fac Hlth Sci, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[4] Univ British Columbia, Fac Med, Kelowna, BC, Canada
[5] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA USA
[6] Monash Univ, Cent Clin Sch, Resp Res Alfred, Melbourne, Vic, Australia
[7] Austin Hlth, Dept Resp & Sleep Med, Heidelberg, Vic, Australia
[8] Inst Breathing & Sleep, Heidelberg, Vic, Australia
[9] Univ Melbourne, Fac Med, Melbourne, Vic, Australia
[10] Hosp Coracao, Hcor Res Inst, Sao Paulo, Brazil
[11] Univ Sao Paulo, Pulm Div, Sao Paulo, Brazil
[12] Stat Norway, Oslo, Norway
[13] Imperial Coll London, Natl Heart & Lung Inst, Margaret Turner Warwick Ctr Fibrosing Lung Dis, London, England
[14] McMaster Univ, Dept Med, Hamilton, ON, Canada
[15] McMaster Univ, Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[16] McMaster Univ, Dept Anesthesiol, Hamilton, ON, Canada
关键词
IPF; Prognostic factors; Acute exacerbations; Meta-analysis; INTERSTITIAL PNEUMONIA; THROMBOMODULIN; EFFICACY; INDEX; BIAS;
D O I
10.1016/j.rmed.2023.107515
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) increases mortality risk, but which factors increase mortality is unknown. We aimed to perform a prognostic review of factors associated with mortality in patients with IPF. Study design: and methods: We searched MEDLINE, EMBASE, and CINAHL for studies that reported on the association between any prognostic factor and AE-IPF. We assessed risk of bias using the QUIPS tool. We conduced pairwise meta -analyses using REML heterogeneity estimator, and GRADE approach to assess the certainty of the evidence. Results: We included 35 studies in our analysis. We found that long-term supplemental oxygen at baseline (aHR 2.52 [95 % CI 1.68 to 3.80]; moderate certainty) and a diagnosis of IPF compared to non-IPF ILD (aHR 2.19 [95 % CI 1.22 to 3.92]; moderate certainty) is associated with a higher risk of death in patients with AE-IPF. A diffuse pattern on high resolution computed tomography (HRCT) compared to a non -diffuse pattern (aHR 2.61 [95 % CI 1.32 to 2.90]; moderate certainty) is associated with a higher risk of death in patients with AE-IPF. We found that using corticosteroids prior to hospital admission (aHR 2.19 [95 % CI 1.26 to 3.82]; moderate certainty) and those with increased neutrophils (by % increase) in bronchoalveolar lavage (BAL) during the exacerbation is associated with a higher risk of death (aHR 1.02 [1.01 to 1.04]; moderate certainty). Interpretation: Our results have implications for healthcare providers in making treatment decisions and prognosticating the clinical trajectory of patients, for researchers to design future interventions to improve patient trajectory, and for guideline developers in making decisions about resource allocation.
引用
下载
收藏
页数:9
相关论文
共 50 条
  • [41] Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis
    Skandamis, Aristeidis
    Kani, Chara
    Markantonis, Sophia L.
    Souliotis, Kyriakos
    JOURNAL OF DRUG ASSESSMENT, 2019, 8 (01) : 55 - 61
  • [42] Treatment of Gastroesophageal Reflux in Patients With Idiopathic Pulmonary Fibrosis A Systematic Review and Meta-Analysis
    Fidler, Lee
    Sitzer, Nicole
    Shapera, Shane
    Shah, Prakesh S.
    CHEST, 2018, 153 (06) : 1405 - 1415
  • [43] The Impact of Occupational Exposures on the Risk of Idiopathic Pulmonary Fibrosis - A Systematic Review and Meta-analysis
    Gandhi, S.
    Min, B.
    Johannson, K. A.
    Steinmaus, C.
    Reynolds, C.
    Cummings, K. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [44] DRUG THERAPY FOR TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Canestaro, W. J.
    Forrester, S.
    Ho, L.
    Devine, B.
    VALUE IN HEALTH, 2015, 18 (03) : A170 - A170
  • [45] Effectiveness and Safety of Chinese Medicine for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
    WU Qi
    ZHOU Yao
    FENG Fanchao
    ZHOU Xianmei
    Chinese Journal of Integrative Medicine, 2019, 25 (10) : 778 - 784
  • [46] Impact of idiopathic pulmonary fibrosis in lung cancer patients: a systematic review and meta-analysis
    Zheng, Xinlin
    Chen, Linsong
    Zhang, Lin
    Xia, Xueyang
    Ding, Hongdou
    Ma, Jianxing
    Jiang, Peng
    Li, Bin
    Zheng, Chenzhao
    Zhao, Yanfeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 378 - 391
  • [47] Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
    Sun, Tong
    Liu, Jing
    Zhao, De Wei
    MEDICINE, 2016, 95 (19)
  • [48] Acute exacerbations in idiopathic pulmonary fibrosis
    Crowley, SP
    Kelly, P
    Egan, JJ
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (03) : 218 - 218
  • [49] COMBINATION THERAPY WITH PIRFENIDONE AND NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Gandhi, Tanmay
    Shah, Aniruddh
    Saluja, Prachi
    Kocurek, Emily
    CHEST, 2023, 164 (04) : 3027A - 3027A
  • [50] The effects and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a meta-analysis and systematic review
    Zang, Chenchen
    Zheng, Yan
    Wang, Yanqing
    Li, Lisha
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2021, 26 (01)